Longeveron (LGVN) Receivables - Net (2021 - 2026)
Longeveron (LGVN) recorded quarterly Receivables - Net of $68000.0 in Q1 2026, down 34.62% quarter-over-quarter from $104000.0 in Q4 2025, and up 134.48% on a YoY basis from $29000.0 in Q1 2025.
Longeveron (LGVN) Receivables - Net (2021 - 2026) Analysis & Trends
Longeveron's Receivables - Net history runs 6 years deep, the most recent figure standing at $68000.0 for Q1 2026.
- In Q1 2026, Receivables - Net rose 134.48% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at $68000.0 (up 134.48% YoY), while the FY2025 annual figure was $104000.0, up 23.81% from the prior year.
- Receivables - Net was $68000.0 for Q1 2026 at Longeveron, down from $104000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $380000.0 in Q3 2024 to a low of $29000.0 in Q1 2025.
- Historically, Receivables - Net has averaged $125785.7 across 5 years, with a median of $96000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Receivables - Net soared 296.36% in 2022, then plunged 86.32% in 2025.
- A 5-year view of Receivables - Net shows it stood at $218000.0 in 2022, then tumbled by 49.08% to $111000.0 in 2023, then declined by 24.32% to $84000.0 in 2024, then advanced by 23.81% to $104000.0 in 2025, then plunged by 34.62% to $68000.0 in 2026.
- The last three Receivables - Net figures came in at $68000.0 (Q1 2026), $104000.0 (Q4 2025), and $52000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Dec 31, 2025 | 104,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Mar 31, 2025 | 29,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Sep 30, 2024 | 380,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Jun 30, 2024 | 218,000.00 |
| Mar 31, 2024 | 178,000.00 |
| Mar 31, 2024 | 178,000.00 |
| Dec 31, 2023 | 111,000.00 |
| Dec 31, 2023 | 111,000.00 |